Last checked at 28 Jul 2017 07:00
Surgical Innovations Group plc
(the "Company")
Director/PDMR Shareholdings
The Company was notified on 27 July 2017 of the following purchases of ordinary shares of 1p each ("Ordinary Shares") on that day by directors of the Company.
Nigel Rogers, Executive Chairman, acquired 400,000 Ordinary Shares for his SIPP at a price of 3.49 pence per share. Following this transaction, Mr. Rogers' shareholding is 4,093,478 Ordinary Shares, representing 0.76% of the issued share capital.
Paul Hardy, Non-Executive Director, acquired 815,721 Ordinary Shares for his SIPP at a price of 3.49p per share. Following this transaction, Mr. Hardy's shareholding is 5,191,195 Ordinary Shares, representing 0.97% of the issued share capital.
For the avoidance of doubt, the shareholdings shown above and the issued share capital used in the calculation of the percentages do not include the Ordinary Shares to be issued in connection with the vendor placing, subscriptions and acquisition of Elemental Healthcare Limited announced by the Company on 27 July 2017. Such Ordinary Shares are expected to be issued and allotted on 1 August 2017.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired.
For further information please visit www.sigroupplc.com or contact:
Enquiries:
For further information please contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, COO & CFO |
|
|
|
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather |
|
|
|
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Nigel Rogers | ||||
2 | Reason for the notification | |||||
a) | Position/status | Executive Chairman, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
400,000 £13,960 | ||||
e) | Date of the transaction | 27 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM | ||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Paul Hardy | ||||
2 | Reason for the notification | |||||
a) | Position/status | Non-Executive Director, Surgical Innovations Group plc | ||||
b) | Initial notification/ Amendment | Initial Notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Surgical Innovations Group plc | ||||
b) | LEI | 2138004GHGUH3HUZE156 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704
| ||||
b) | Nature of the transactions | Purchase of Ordinary Shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information - Aggregated volume - Price |
815,721 £28,469 | ||||
e) | Date of the transaction | 27 July 2017 | ||||
f) | Place of the transaction | London Stock Exchange, AIM | ||||